Finance

Lists
VACBF:OTCMKTS
Nykode Therapeutics ASA
$0.45
0.00%
(0.00) 1D
Sep 14, 11:52:37 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VACBF...
Avg. vol.
100.00
Volume
0.00
52-wk high
$0.45
52-wk low
$0.16
Beta
0.53
Shares outstanding
391.55M
No. of employees
59
Avg. vol.
100.00
Volume
0.00
52-wk high
$0.45
52-wk low
$0.16
Beta
0.53
Shares outstanding
391.55M
No. of employees
59
News stories
From web sources and news partners
About Nykode Therapeutics ASA
CEOMichael Engsig
Employees59
Founded2006
Headquarters-
SectorBiotechnology
Websitenykode.com
Previous reportsAll values in NOK
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
118.00K
-
240.00K
106.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.06M
4.16M
2.87M
2.29M
Operating expense
6.40M
8.09M
6.78M
6.85M
Total operating expenses
6.40M
8.09M
6.78M
6.85M
Operating income
-6.28M
-8.09M
-6.54M
-6.74M
Other non operating income
-
-
-
-
EBT including unusual items
-4.98M
-8.04M
-4.11M
-7.16M
EBT excluding unusual items
-4.98M
-8.04M
-4.11M
-7.16M
Income tax expense
-1.32M
-50.00K
7.00K
22.00K
Effective tax rate
26.45%
0.62%
-0.17%
-0.31%
Other operating expenses
2.83M
3.42M
3.28M
4.07M
Net income
-3.66M
-8.00M
-4.11M
-7.18M
Net profit margin
-3,101.69%
-
-1,713.75%
-6,778.30%
Earnings per share
-
-
-
-
Interest and investment income
713.00K
609.00K
518.00K
474.00K
Interest expense
-30.00K
-28.00K
-23.00K
-20.00K
Net interest expenses
683.00K
581.00K
495.00K
454.00K
Depreciation and amortization charges
507.00K
504.00K
624.00K
487.00K
EBITDA
-6.10M
-7.91M
-6.36M
-6.57M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps